UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 118

Sortiert nach

Delay in the Diagnosis of Pediatric Brain Tumors in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis

Neurosurgery, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

CP-10. DOES PRE-IRRADIATION GROSS TUMOR VOLUME PREDICT THE RISK OF PROGRESSION AFTER RADIATION THERAPY IN PEDIATRIC PATIENTS WITH ADAMANTINOMATOUS CRANIOPHARYNGIOMA?

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Link zum Volltext

Verfügbarkeit prüfen

CP-03. EXTRACELLULAR MATRIX REMODELING REVEALS NON-CELL AUTONOMOUS TUMOR FORMATION MECHANISM IN ADAMANTINOMATOUS CRANIOPHARYNGIOMAS

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Link zum Volltext

Verfügbarkeit prüfen

CP-16. PROTEOMIC ANALYSIS OF ADAMANTINOMATOUS CRANIOPHARYNGIOMA REVEALS A COMPLEX NETWORK OF ECM REMODELING

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Link zum Volltext

Verfügbarkeit prüfen

EPEN-24. 5FU SENSITIVITY IS MEDIATED THROUGH TRISOMY UCK2 EXPRESSION IN 1Q+ PFA EPN

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Link zum Volltext

Verfügbarkeit prüfen

CP-12. PHASE 0 AND FEASIBILITY SINGLE-INSTITUTION CLINICAL TRIAL OF INTRAVENOUS TOCILIZUMAB FOR ADAMANTINOMATOUS CRANIOPHARYNGIOMA

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Link zum Volltext

Verfügbarkeit prüfen

IMG-32. USER EVALUATION OF AN AI-POWERED WEB APPLICATION TO SUPPORT RADIOGRAPHIC INTERPRETATION OF PATIENTS WITH ADAMANTINOMATOUS CRANIOPHARYNGIOMA

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Link zum Volltext

Verfügbarkeit prüfen

CP-05. MAPK PATHWAY ACTIVATION, CLONAL EVOLUTION, INCLUDING RARE TP53 LOSS, AND THE IMMUNE ENVIRONMENT OF RECURRENT CRANIOPHARYNGIOMA

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Link zum Volltext

Verfügbarkeit prüfen

IMMU-20. INNATE IMMUNE EVASION IN MYC-AMPLIFIED MEDULLOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Link zum Volltext

Verfügbarkeit prüfen

EPEN-07. A MULTICENTER STUDY OF POOR PROGNOSIS CHROMOSOME 1Q GAIN AND/OR 6Q LOSS IN POSTERIOR FOSSA A EPENDYMOMA SHOWS INCREASED PREVALENCE FROM 20% AT DIAGNOSIS TO 60% AT FIRST RECURRENCE

Neuro-oncology (Charlottesville, Va.), 2023-06, Vol.25 (Supplement_1), p.i28-i28

2023

Link zum Volltext

Verfügbarkeit prüfen

RARE-17. Multi-institutional craniopharyngioma cohort highlights need for more comprehensive data collection on comorbidities and quality of life

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i13-i13

2022

Link zum Volltext

Verfügbarkeit prüfen

IMG-08. Response assessment for pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i78-i78

2022

Link zum Volltext

Verfügbarkeit prüfen

RARE-13. Clinical management and functional and survival outcomes in pediatric craniopharyngioma, a patient and family perspective

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i12-i12

2022

Link zum Volltext

Verfügbarkeit prüfen

RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Suppl 1), p.i15-i15

2022

Link zum Volltext

Verfügbarkeit prüfen

RARE-24. The use of novel in vitro models to study adamantinomatous craniopharyngioma disease biology and drug response

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i15-i15

2022

Link zum Volltext

Verfügbarkeit prüfen

RARE-29. Transcriptome characterization of pediatric adamantinomatous craniopharyngioma at the cellular level

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i16-i16

2022

Link zum Volltext

Verfügbarkeit prüfen

RARE-22 Characterizing the landscape of structural variants in adamantinomatous craniopharyngioma

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i14-i14

2022

Link zum Volltext

Verfügbarkeit prüfen

EPEN-29. Spatial transcriptomic analysis of ependymoma implicates unresolved wound healing as a driver of tumor progression

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i45-i45

2022

Link zum Volltext

Verfügbarkeit prüfen

EPEN-16. Epithelial Progenitor Cell Abundance and Copy Number Variant Gains and Losses Impact the Biology of Recurrent Ependymoma

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i41-i42

2022

Link zum Volltext

Verfügbarkeit prüfen

RARE-32. Phase 0 and feasibility single-institution clinical trial of intravenous tocilizumab for adamantinomatous craniopharyngioma

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i17-i17

2022

Link zum Volltext

Verfügbarkeit prüfen

EPEN-11. Phase 0/I Study of GM-CSF and Intrathecal Trastuzumab In Children With Recurrent Posterior Fossa Ependymoma

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i40-i40

2022

Link zum Volltext

Verfügbarkeit prüfen

Converting Pediatric Patients and Young Adults From a Shunt to a Third Ventriculostomy: A Multicenter Evaluation

Neurosurgery, 2021-12, Vol.89 (Supplement_2), p.S2-S2

2021

Link zum Volltext

Verfügbarkeit prüfen

Occipital-Cervical Fusion and Ventral Decompression in the Surgical Management of Chiari-1 Malformation and Syringomyelia: Analysis of Data From the Park-Reeves Syringomyelia Research Consortium

Neurosurgery, 2021-12, Vol.89 (Supplement_2), p.S89-S89

2021

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma

Nature communications, 2021-09, Vol.12 (1), p.5531-5531, Article 5531

2021

Link zum Volltext

Verfügbarkeit prüfen

EMBR-27. NEOPLASTIC AND IMMUNE SINGLE CELL TRANSCRIPTOMICS DEFINE SUBGROUP-SPECIFIC INTRA-TUMORAL HETEROGENEITY OF CHILDHOOD MEDULLOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2021-06, Vol.23 (Supplement_1), p.i11-i12

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 118

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Zeitschrift / SerieJournal Of Neurosurgery. Pediatrics

Nur zeigenMit Volltextzugriff

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)

Publikationsform

Sprache

Englisch
(118)
Japanisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Delay in the Diagnosis of Pediatric Brain Tumors in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis

CP-10. DOES PRE-IRRADIATION GROSS TUMOR VOLUME PREDICT THE RISK OF PROGRESSION AFTER RADIATION THERAPY IN PEDIATRIC PATIENTS WITH ADAMANTINOMATOUS CRANIOPHARYNGIOMA?

CP-03. EXTRACELLULAR MATRIX REMODELING REVEALS NON-CELL AUTONOMOUS TUMOR FORMATION MECHANISM IN ADAMANTINOMATOUS CRANIOPHARYNGIOMAS

CP-16. PROTEOMIC ANALYSIS OF ADAMANTINOMATOUS CRANIOPHARYNGIOMA REVEALS A COMPLEX NETWORK OF ECM REMODELING

EPEN-24. 5FU SENSITIVITY IS MEDIATED THROUGH TRISOMY UCK2 EXPRESSION IN 1Q+ PFA EPN

CP-12. PHASE 0 AND FEASIBILITY SINGLE-INSTITUTION CLINICAL TRIAL OF INTRAVENOUS TOCILIZUMAB FOR ADAMANTINOMATOUS CRANIOPHARYNGIOMA

IMG-32. USER EVALUATION OF AN AI-POWERED WEB APPLICATION TO SUPPORT RADIOGRAPHIC INTERPRETATION OF PATIENTS WITH ADAMANTINOMATOUS CRANIOPHARYNGIOMA

CP-05. MAPK PATHWAY ACTIVATION, CLONAL EVOLUTION, INCLUDING RARE TP53 LOSS, AND THE IMMUNE ENVIRONMENT OF RECURRENT CRANIOPHARYNGIOMA

IMMU-20. INNATE IMMUNE EVASION IN MYC-AMPLIFIED MEDULLOBLASTOMA

EPEN-07. A MULTICENTER STUDY OF POOR PROGNOSIS CHROMOSOME 1Q GAIN AND/OR 6Q LOSS IN POSTERIOR FOSSA A EPENDYMOMA SHOWS INCREASED PREVALENCE FROM 20% AT DIAGNOSIS TO 60% AT FIRST RECURRENCE

RARE-17. Multi-institutional craniopharyngioma cohort highlights need for more comprehensive data collection on comorbidities and quality of life

IMG-08. Response assessment for pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group

RARE-13. Clinical management and functional and survival outcomes in pediatric craniopharyngioma, a patient and family perspective

RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response

RARE-24. The use of novel in vitro models to study adamantinomatous craniopharyngioma disease biology and drug response

RARE-29. Transcriptome characterization of pediatric adamantinomatous craniopharyngioma at the cellular level

RARE-22 Characterizing the landscape of structural variants in adamantinomatous craniopharyngioma

EPEN-29. Spatial transcriptomic analysis of ependymoma implicates unresolved wound healing as a driver of tumor progression

EPEN-16. Epithelial Progenitor Cell Abundance and Copy Number Variant Gains and Losses Impact the Biology of Recurrent Ependymoma

RARE-32. Phase 0 and feasibility single-institution clinical trial of intravenous tocilizumab for adamantinomatous craniopharyngioma

EPEN-11. Phase 0/I Study of GM-CSF and Intrathecal Trastuzumab In Children With Recurrent Posterior Fossa Ependymoma

Converting Pediatric Patients and Young Adults From a Shunt to a Third Ventriculostomy: A Multicenter Evaluation

Occipital-Cervical Fusion and Ventral Decompression in the Surgical Management of Chiari-1 Malformation and Syringomyelia: Analysis of Data From the Park-Reeves Syringomyelia Research Consortium

Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma

EMBR-27. NEOPLASTIC AND IMMUNE SINGLE CELL TRANSCRIPTOMICS DEFINE SUBGROUP-SPECIFIC INTRA-TUMORAL HETEROGENEITY OF CHILDHOOD MEDULLOBLASTOMA

Aktive Filter

Suchergebnisse filtern